Don't get me wrong...I am confident RVX will get bought out. 

I think all this is very positive for RVX: a great CTAD presentation, an FDA letter and hopefully the data on eGFR improvements for the low eGFR group. 

However, I don't think all of these combined won't move the share price much.  The reason is that with these unlisted (non-insider) warrant owners winning a jackpot, the market will perceive a natural and technical lid on the share price.

The only thing that will start moving the share price in earnest is an actual bid.  Do we enough competitive tension for a bidder to make an early move?  I don't know, but I don't think we can assume that a big company has had enough time to do all the due diligence to put in a bid.  I am resigned to a bid coming not right now, but in 2020.  Big companies don't move that fast.  Naturally, I would love to be wrong.